South Korea’s leading bio-tech companies join forces to establish 'Vaccine Innovation Council'
South Korea’s vaccine companies have decided to launch a “Vaccine Innovation Council” to establish vaccine sovereignty, enhance international competitiveness, and cooperate with the aim of strengthening research and development (R&D) capabilities in the vaccine industry.
South Korea’s Ministry of Health and Welfare and the Vaccine Innovative Technology Alliance Korea hosted the launch ceremony for the Vaccine Innovation Council; 14 major Korean vaccine companies participated. The Council plans to conduct research on vaccine development, strengthen R&D capabilities, and cooperate with the government to produce countermeasures in the event of a national health crisis caused by infectious disease. The Council intends to help South Korea respond to future infectious diseases based on strengthened vaccine development capabilities.